Key result
Carboplatin substitution for cisplatin in the treatment of ovarian carcinoma warrants caution.
Why the study?
Does carboplatin substitution for cisplatin affect outcomes in patients with ovarian carcinoma?
Does carboplatin substitution for cisplatin affect outcomes in patients with ovarian carcinoma?
This editorial discusses a word of caution regarding the substitution of carboplatin for cisplatin in the treatment of ovarian carcinoma.
William P. McGuire, Martin D. Abeloff; Carboplatin Substitution for Cisplatin in the Treatment of Ovarian Carcinoma— A Word of Caution, JNCI: Journal of the Nat
No takes yet. Share an insight, caveat, or question.
McGuire et al. (1989) studied this question. Carboplatin substitution for cisplatin in the treatment of ovarian carcinoma warrants caution.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: